Projects per year
Personal profile
Chinese Name
Biography
Prof. Yu received his undergraduate education at the Henan University of Traditional Chinese Medicine, and obtained his PhD degree in biochemistry from the Hong Kong University of Science and Technology. Before joining the Hong Kong Baptist University, Prof. Yu once worked at China Pharmaceutical University, Nagasaki University, Hong Kong University of Science and Technology, Xiamen University and University of Macau. Prof. Yu is known for his research in herbal pharmacology, and in processing of Chinese medicinal materials. He has published more than 200 peer-reviewed research papers.
Consun Pharmaceutical Group Limited and Laboratory JaneClare Limited in collaboration with Prof. Yu's team established "Consun Chinese Medicines Research Centre for Renal Diseases" and "JaneClare Transdermal TCM Therapy Laboratory", respectively, in Hong Kong Baptist University.
Prof. Yu serves as Editorial Board Member/Associate Editor/Executive Editor/ Consulting Editor for more than 30 journals, e.g. LiShizhen Medicine and Materia Medica Research, BMC Complementary Medicine and Therapies, Current Topics in Nutraceutical Research, Journal of Alternative, Complementary & Integrative Medicine, Pharmacological Research.
Research Interests
1) Pharmacology of Chinese medicines, focusing on the mechanisms of action of anticancer, anti-inflammation and melanogenesis-modulation herbs; 2) Unique processing of Chinese medicinal herbs, focusing on the mechanisms underlying processing of Chinese medicines, standardization of adjuvant materials for the processing of Chinese medicinal herbs, and quality control of decoction pieces.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Scholars
Collaborations and top research areas from the last five years
-
Pharmacological Studies for Developing Si-Jun-Zi-Tang Extract as an Adjuvant of Temozolomide in Treating Glioblastoma
YU, Z. (PI)
27/03/24 → 15/05/25
Project: Research project
-
Pharmacological Studies for Developing Si-Jun-Zi-Tang Extract as an Adjuvant of Temozolomide in Treating Glioblastoma
YU, Z. (PI)
27/03/24 → 15/05/25
Project: Research project
-
靶向DNA复制起始蛋白的共同转录因子PAX2治疗癌症 Targeting PAX2, a common transcriptional regulator of DNA replication-initiation proteins, for treating cancer
YU, Z. (PI), FU, X. (CoI), WANG, L. (CoI), WANG, X. (CoI) & WU, J. (CoI)
1/01/24 → 31/12/26
Project: Research project
-
Pharmacological Studies for Developing Si-Jun-Zi-Tang Extract as an Adjuvant of Temozolomide in Treating Glioblastoma
YU, Z. (PI), FU, X. (CoI), LI, S. M. A. (CoI), WU, J. (CoI) & WANG, X. (CoI)
16/11/23 → 15/05/25
Project: Research project
-
Investigation of Anti-melanoma Mechanisms and Targeted Delivery of Isoliquiritigenin
YU, Z. (CoPI) & Liu, Q. (CoPI)
1/07/23 → 30/06/25
Project: Research project
-
A tri-compound formula comprising ginsenoside Rg1, tetrandrine and icariin alleviates atopic dermatitis symptoms in a mouse model
Wu, Y., Wang, X.-Q., Wu, J.-Y., Chen, Y.-J., Bai, J.-X., Li, A.S.-M., Fan, X.-Y., Wong, L.-Y., Wang, L., Fu, X.-Q. & Yu, Z.-L., 7 Apr 2025, (E-pub ahead of print) In: Phytomedicine. 141, 21 p., 156737.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Dietary supplementation with milk-derived Bifidobacterium animalis subsp. lactis relieves colitis-linked reproductive disorders via gut-testis axis
Lin, J., Yin, L., Fan, Y., Yu, Z., Ma, X., Fu, X., Zhang, Y., Tang, S. & Chen, J., Mar 2025, In: iMetaOmics. 2, 1, 19 p., e49.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Metabolic restoration: Rhubarb polysaccharides as a shield against non-alcoholic fatty liver disease
Qiu, J., Xu, F., Wei, H., Gao, Y., Liu, N., Zhao, J., Yu, Z., Chen, L. & Dou, X., May 2025, In: International Journal of Biological Macromolecules. 305, 14 p., 141151.Research output: Contribution to journal › Journal article › peer-review
-
A critical review on intestinal mucosal barrier protection effects of dietary polysaccharides
Yan, W., Luo, J., Yu, Z. & Xu, B., Jan 2024, In: Food and Function. 15, 2, p. 481-492 12 p.Research output: Contribution to journal › Journal article › peer-review
13 Citations (Scopus) -
Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway
Wu, Y., Dai, S., Zhang, Y. J., Li, Z., Zhu, B., Liu, Q., Wo, L., Yu, Z., Yuan, X. & Dou, X., 11 Jun 2024, In: Journal of Cancer. 15, 13, p. 4328-4344 17 p.Research output: Contribution to journal › Journal article › peer-review
Open Access2 Citations (Scopus)
Prizes
-
File
-
Certificate for Excellence for an abstract presented at the 2022 World Federation of Chinese Medicine Societies Meeting
FAN, X. (Recipient), WU, Y. (Recipient), FU, X. (Recipient) & YU, Z. (Recipient), 23 Jun 2023
Prize: Award
File
Activities
-
Current Research on Complementary and Alternative Medicine (Journal)
YU, Z. (Member of editorial board)
14 Feb 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Oncology Research (Journal)
YU, Z. (Member of editorial board)
20 Feb 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Current Traditional Medicine (Journal)
YU, Z. (Member of editorial board)
Jan 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Journal of Medicine and HealthCare (Journal)
YU, Z. (Member of editorial board)
16 Apr 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Biocell (Journal)
YU, Z. (Member of editorial board)
10 May 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)